Characterization of peripheral blood T-lymphocytes transduced with HTLV-I Tax mutants with different trans-activating phenotypes

Oncogene

Volumn 14, Issue 17, 1997, Pages 2071-2078

  Akagi, Tsuyoshi ^a   Ono, Hiroaki ^a   Nyunoya, Hiroshi ^a   Shimotohno, Kunitada ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

CD4; CD8; CREB ATF; HTLV I; NF B; Tax

Indexed keywords

CD4 ANTIGEN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; MUTANT PROTEIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; GENE ACTIVATION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; LYMPHOCYTE CLONE; LYMPHOCYTE PROLIFERATION; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RETROVIRUS; T LYMPHOCYTE; TRANSACTIVATION; VIRUS CARCINOGENESIS; VIRUS MUTANT;

EID: 0030976361     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201045     Document Type: Article

References (47)

1. Abe Y, Van Eden M, Gatanaga M, Wang FI, Brightbill HD, Granger GA and Gatanaga T. (1993). Lymphokine & Cytokine Research, 12, 279-283.
2. Akagi T, Nyunoya H and Shimotohno K. (1991). Gene, 106, 255-259.
3. Akagi T. Ono H, Sasaki T and Shimotohno K. (1995a). FEBS Letters, 358, 34-38.
4. Akagi T, Ono H and Shimotohno K. (1995b). Blood, 86, 4243-4249.
5. Akagi T, Ono H and Shimotohno K. (1996). Oncogene, 12, 1645-1652.
6. Akagi T and Shimotohno K. (1993). Journal of Virology, 67, 1211-1217.
7. Asano M, Ishida Y, Sabe H, Kondo M, Sugamura K and Honjo T. (1994). Journal of Immunology, 153, 5373-5381.
8. Bailly S, Fay M, Israel N and Gougerot-Pocidalo MA. (1996). European Cytokine Network, 7, 125-128.
9. Cereseto A, Diella F, Mulloy JC, Cara A, Michieli P, Grassmann R, Franchini G & Klotman ME. (1996). Blood, 88, 1551-1560.
10. Cheng J and Haas M. (1990). Molecular & Cellular Biology, 10, 5502-5509.
11. Curtiss VE, Smilde R and McGuire KL. (1996). Molecular & Cellular Biology, 16, 3567-3575.
12. De Rossi A, Aldovini A, Franchini G, Mann D, Gallo RC & Wong-Staal F. (1985). Virology, 143, 640-645.
13. Feuer G & Chen IS. (1992). Biochimica et Biophysica Acta, 1114, 223-233.
14. Franchini G. (1995). Blood, 86, 3619-3639.
15. Fujii M, Tsuchiya H, Chuhjo T, Akizawa T & Seiki M. (1992). Genes & Development, 6, 2066-2076.
16. Good L, Maggirwar SB & Sun SC. (1996). EMBO J., 15, 3744-3750.
17. Grassmann R, Berchtold S, Radant I, Alt M, Fleckenstein B, Sodroski JG, Haseltine WA & Ramstedt U. (1992). Journal of Virology, 66, 4570-4575.
18. Gullberg M & Smith KA. (1986). Journal of Experimental Medicine, 163, 270-284.
19. Hahn B, Gallo RC, Franchini G, Popovic M, Aoki T, Salahuddin SZ, Markham PD & Staal FW. (1984). Molecular Biology & Medicine, 2, 29-36.
20. Harper ME, Kaplan MH, Marselle LM, Pahwa SG, Chayt KJ, Sarngadharan MG, Wong-Staal F and Gallo RC. (1986). New England Journal of Medicine, 315, 1073-1078.
21. Higashimura N, Takasawa N, Tanaka Y, Nakamura M and Sugamura K. (1996). Japanese Journal of Cancer Research, 87, 227-231.
22. Himes SR, Coles LS, Katsikeros R, Lang RK and Shannon MF. (1993). Oncogene, 8, 3189-3197.
23. Hollsberg P and Hafler DA. (1993). New England Journal of Medicine, 328, 1173-1182.
24. Lee HM and Rich S. (1993). Journal of Immunology, 151, 668-677.
25. Markham PD, Salahuddin SZ, Macchi B, Robert-Guroff M and Gallo RC. (1984). International Journal of Cancer, 33, 13-17.
26. Maruyama M, Shibuya H, Harada H, Hatakeyama M, Seiki M, Fujita T, Inoue J, Yoshida M and Taniguchi T. (1987). Cell 48, 343-350.
27. Miller AD, Garcia JV, von Suhr N, Lynch CM, Wilson C and Eiden MV. (1991). Journal of Virology, 65, 2220-2224.
28. Miller AD and Rosman GJ. (1989). Biotechniques, 7, 980-982.
29. Mori N, Murakami S, Oda S and Eto S. (1994a). Blood, 84, 350-351.
30. Mori N & Prager D. (1996). Blood, 87, 3410-3417.
31. Mori N, Shirakawa F, Shimizu H, Murakami S, Oda S, Yamamoto K and Eto S. (1994b). Blood, 84, 2904-2911.
32. Moss B, Elroy-Stein O, Mizukumi T, Alexander WA and Fuerst TR. (1990). Nature, 348, 91-92.
33. Ohbo K, Takasawa N, Ishii N, Tanaka N, Nakamura M and Sugamura K. (1995). Journal of Biological Chemistry, 270, 7479-7486.
34. Shimotohno K, Takano M, Teruuchi T and Miwa M. (1986). Proceedings of the National Academy of Sciences of the United States of America, 83, 81 12- 8116.
35. Smith MR and Greene WC. (1990). Genes & Development, 4, 1875-1885.
36. Smith MR and Greene WC. (1991). Journal of Clinical Investigation, 88, 1038-1042.
37. Smith MR and Greene WC. (1995). Genes & Development, 9, 2324.
38. Soldaini E, MacDonald HR and Nabholz M. (1992). European Journal of Immunology, 22, 1707-1711.
39. Suzuki T, Kitano S, Matsushime H and Yoshida M. (1996). EMBO J., 15, 1607-1614.
40. Tam SW, Shay JW and Pagano M. (1994). Cancer Research, 54, 5816-5820.
41. Tanaka Y, Yoshida A, Tozawa H, Shida H, Nyunoya H and Shimotohno K. (1991). International Journal of Cancer, 48, 623-630.
42. Tatewaki M, Yamaguchi K, Matsuoka M, Ishii T, Miyasaka M, Mori S, Takatsuki K and Watanabe T. (1995). Blood, 86, 3109-3117.
43. van Bergen CA, Smit WM, van Sluijters DA, Rijnbeek M, Willemze R and Falkenburg JH. (1996). Annals of Hematology, 72, 245-252.
44. Yamaoka S, Inoue H, Sakurai M, Sugiyama T, Hazama M, Yamada T and Hatanaka M. (1996). EMBO J., 15, 873-887.
45. Yamashita I, Katamine S, Moriuchi R, Nakamura Y, Miyamoto T, Eguchi K and Nagataki S. (1994). Blood, 84, 1573-1578.
46. Yang SC, Owen-Schaub LB, Roth JA and Grimm EA. (1990). Cancer Research, 50, 3526-3532.
47. Yoshida M. (1993). Trends in Microbiology, 1, 131-135.